Lactodel 2.5 Mg 20 Tablets

Lactodel 2.5 Mg 20 Tablets

Description:

Lactodel 2.5 mg 20 tablets is a prescription oral medicine containing bromocriptine, a dopamine agonist of the ergot alkaloid group. It is primarily used to treat conditions associated with high prolactin levels (hyperprolactinemia), certain cases of Parkinson's disease, and other endocrine disorders. By stimulating dopamine D2 receptors, Lactodel helps normalize prolactin secretion, improve menstrual irregularities, reduce abnormal breast milk production, and support the management of Parkinsonian symptoms under medical supervision.

Indications:

• Treatment of hyperprolactinemia-associated disorders such as amenorrhea (absence of menstruation) and galactorrhea (inappropriate breast milk production).
• Management of Parkinson's disease symptoms as an adjunct or alternative to levodopa therapy, as directed by a neurologist.
• Adjunctive treatment of acromegaly (excess growth hormone) to help reduce growth hormone and prolactin levels.
• Suppression of established lactation in specific medical situations when breastfeeding must be stopped (only under strict medical advice).
• May be used in selected endocrine or neurological conditions such as premenstrual syndrome, Cushing's syndrome, and hepatic encephalopathy as determined by a specialist.

Active Ingredients / Key Components:

• Bromocriptine mesylate – 2.5 mg per tablet (dopamine D2 receptor agonist, ergot-derived).
• Excipients: The full list of inactive ingredients (tablet core and coating) is not available in the provided data. Please refer to the printed package leaflet for complete excipient information.

Dosage & Administration / How to Use:

• Use only as prescribed by your doctor. Dosage varies according to indication (Parkinson's disease, hyperprolactinemia, acromegaly, or lactation suppression) and patient response.
• Tablets are usually taken orally with food to reduce gastrointestinal side effects such as nausea and vomiting.
• For hyperprolactinemia and galactorrhea: treatment often starts with a low dose (e.g., 1.25 mg once or twice daily) and may be gradually increased. Exact dosing schedule must be determined by the physician.
• For Parkinson's disease: therapy is typically initiated at a low dose and slowly titrated upward to minimize side effects and find the lowest effective dose.
• For suppression of established lactation or other endocrine indications: follow the exact regimen prescribed by your healthcare provider; do not adjust the dose on your own.
• Swallow the tablet whole with a glass of water; do not crush or chew unless advised otherwise by your doctor or pharmacist.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Duration of treatment depends on the condition being treated and clinical response; do not stop treatment abruptly without consulting your doctor.

Clinical Benefits:

• Helps normalize elevated prolactin levels, improving menstrual cycle regularity and fertility in women with hyperprolactinemia.
• Reduces inappropriate breast milk production (galactorrhea) and associated discomfort.
• Provides dopaminergic activity in the brain to help improve motor symptoms in Parkinson's disease, such as rigidity and bradykinesia, when used as part of a comprehensive treatment plan.
• Assists in the management of acromegaly by helping to reduce growth hormone and prolactin secretion in selected patients.
• Offers a targeted hormonal approach for certain endocrine-related conditions (e.g., premenstrual syndrome, Cushing's syndrome) when prescribed by a specialist.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to bromocriptine, other ergot alkaloids, or any component of the formulation.
• Contraindicated in uncontrolled hypertension, severe cardiovascular disease, and in patients with a history of serious psychiatric disorders unless the potential benefit clearly outweighs the risk and under strict supervision.
• Use with caution in patients with liver impairment, kidney disease, peptic ulcer, or a history of gastrointestinal bleeding.
• May cause sudden sleep onset, dizziness, or low blood pressure; avoid driving or operating machinery until you know how the medicine affects you.
• Consult your doctor before use if pregnant or planning pregnancy. Bromocriptine is sometimes used in fertility treatment, but must be strictly supervised by a specialist.
• Do not use for routine suppression of lactation after normal childbirth unless clearly indicated and prescribed by a physician due to potential serious side effects.
• Inform your doctor about all other medications you are taking, especially other dopamine agonists, antipsychotics, antihypertensives, macrolide antibiotics, or ergot derivatives, due to possible interactions.
• Consult your doctor before use if you have a history of heart valve disease, Raynaud's phenomenon, or severe vascular disease.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, abdominal discomfort, constipation, headache, dizziness, fatigue, and nasal congestion.
• Some patients may experience low blood pressure (especially when standing), fainting, or drowsiness; rise slowly from sitting or lying positions.
• Less common but serious side effects can include hallucinations, confusion, severe headache, vision changes, chest pain, shortness of breath, severe abdominal pain, or signs of heart or lung complications. Seek immediate medical attention if these occur.
• Rarely, long-term use of ergot-derived dopamine agonists has been associated with fibrotic reactions (e.g., cardiac valvulopathy, pulmonary or retroperitoneal fibrosis). Regular medical follow-up is essential.
• If you experience allergic reactions such as rash, itching, swelling of the face or throat, or difficulty breathing, stop the medicine and seek urgent medical help.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at the temperature conditions specified in the package insert.

Specifications:

• Active ingredient: bromocriptine mesylate 2.5 mg per tablet.
• Form: oral tablet.
• Pack size: 20 tablets per pack.
• Intended use: prescription medicine for Parkinson's disease and hyperprolactinemic disorders, and other specified endocrine conditions under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.